Details for New Drug Application (NDA): 219116
The generic ingredient in BUMETANIDE is bumetanide. There is one drug master file entry for this compound. Forty suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 219116
| Tradename: | BUMETANIDE |
| Applicant: | Qilu Pharm Hainan |
| Ingredient: | bumetanide |
| Patents: | 0 |
Pharmacology for NDA: 219116
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 219116
Suppliers and Packaging for NDA: 219116
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 219116 | ANDA | Qilu Pharmaceutical Co., Ltd. | 67184-0593 | 67184-0593-2 | 10 VIAL in 1 CARTON (67184-0593-2) / 4 mL in 1 VIAL (67184-0593-1) |
| BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 219116 | ANDA | Qilu Pharmaceutical Co., Ltd. | 67184-0594 | 67184-0594-2 | 10 VIAL in 1 CARTON (67184-0594-2) / 10 mL in 1 VIAL (67184-0594-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.25MG/ML | ||||
| Approval Date: | Sep 19, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
